Braeden Lichti
Braeden Lichti | |
|---|---|
 | |
| Born | Braeden William Lichti |
| Nationality | Canadian |
| Citizenship | United Kingdom, Canada |
| Occupation | |
| Organization |
|
| Website | bwlinvestments |
Braeden Lichti is a Canadian business professional and entrepreneur that has spent more than 15 years creating and identifying value in various financial markets.[1][2] Mr. Lichti is the founder and CEO of BWL Investments, a public markets venture capital investment firm, and also manages NorthStrive Companies Inc., a US wholly owned subsidiary of BWL Investments Ltd.[3] Mr. Lichti is also a Co-Founder and investor at ELEVAI Labs Inc.[4][5][6] and he Co-Founded Health Logic Interactive Inc., which eventually sold its operating subsidiary to Marizyme, Inc., in Q4 2021.[7]
As an active investor, Mr. Lichti typically takes board seats and invests in emerging companies in the biotechnology and medical aesthetic space and utilizes the public markets to facilitate larger follow-on institutional funding rounds.[8] Mr. Lichti is known as a public market venture capital investor and is recognized as an expert in restructuring, financing, and creating many companies that have been listed on national stock exchanges or have been bought out.[9][10][11]
Early life
Braeden was born in Winnipeg, Manitoba, and raised in Vancouver, Canada. Braeden also moved to London, England in 2014 and resided in west London for many years.[12] He attributes his interest in capital markets and entrepreneurship to his late father, an investment banker, who taught him at an early age how to undertake company due diligence and research on public companies before making an investment decision. At age 15, Lichti began investing through a broker in several Canadian-listed equities and has been active ever since. He has maintained this long-standing interest in investing in early-stage ventures and building companies and credits much of his success from not only taking risks but learning from mistakes he made along the way and his strong sense of independence, and contrarian views which have been a mindset of his since his early teens.[12]
Career
Lichti established BWL Investments in 2016 and has remained its CEO since its inception.[13] BWL Investments is a private Canadian company specializing in creating and identifying public markets venture capital investment opportunities across global industries, such as pharmaceuticals, medical devices and aesthetics, and biotechnology.[14][15][16]
Lichti is the co-founder and investor of ELEVAI Labs Inc., a biotechnology company established in 2020 that specializes in advanced regenerative skincare solutions for the physician-dispensed market.[17][18]
Lichti previously co-founded Health Logic Interactive Inc., a TSX-listed diagnostic company that developed a device for chronic kidney disease diagnosis, which was later acquired by Marizyme Inc. in 2021.[19][20]
Additionally, Lichti manages NorthStrive Companies Inc., the US wholly owned subsidiary of BWL Investments Ltd. NorthStrive is focused on US biotech and medical aesthetics venture capital opportunities.[21][22] Additionally, Lichti has been a published author in leading in aesthetic medical skincare publications.[23][24]
In 2023, Braeden Lichti led a shareholder activist campaign[25] to remove the board of Hydromer Inc. His efforts culminated in the successful removal of the entire board. Following this transition, Lichti was appointed as the Executive Chairman, accompanied by a new set of directors.[26][27]
In the media
References
- ↑ "Braeden William Lichti". Medium. Retrieved 7 December 2022.
- ↑ "Elevai Labs Company Profile: Valuation & Investors | PitchBook". pitchbook.com. Retrieved 7 December 2022.
- ↑ "inmune_corresp.htm". www.sec.gov. Retrieved 16 December 2022.
- ↑ "Six Questions with Investor Braeden Lichti". PharmaVOICE. Retrieved 7 December 2022.
- ↑ "My Health Logic Announces Debt Financing". www.newswire.ca. Retrieved 7 December 2022.
- ↑ "Braeden Lichti Shares Insight on the Challenges Early Stage Companies Face, Why to Avoid Trying to Time the Market and How to Prepare for the Unforeseen Regulation Risk | Madison Graph". www.madisongraph.com/. Retrieved 19 April 2024.
- ↑ "HEALTH LOGIC INTERACTIVE ANNOUNCES THE CLOSING OF ITS SALE OF ITS WHOLLY OWNED SUBSIDIARY". finance.yahoo.com. Retrieved 19 December 2022.
- ↑ "Health Logic Interactive Insider Trading & Ownership Structure". Simply Wall St. Retrieved 7 December 2022.
- ↑ Azma, Sheeva; Investments, on behalf of BWL. "6 questions for investor Braeden Lichti". MedCity News. Retrieved 7 December 2022.
- ↑ "INmune Bio Inc. Rings the Nasdaq Closing Bell | By Nasdaq | Facebook". www.facebook.com. Retrieved 16 December 2022.
- ↑ Biosciences, Artelo (21 June 2019). "Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to Nasdaq". GlobeNewswire News Room. Retrieved 16 December 2022.
- ↑ 12.0 12.1 "LICHTI | Find people whose family name is LICHTI at locatefamily.com (Page 2 of 11) | Locate Family | Find people for FREE!". www.locatefamily.com. Retrieved 20 December 2022.
- ↑ "BWL Investments – BWL Investments". bwlinvestments.com. Retrieved 19 April 2024.
- ↑ "INmune Bio Inc. Announces Closing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol "INMB"". GlobeNewswire News Room. 4 February 2019. Retrieved 19 April 2024.
- ↑ Etkin, Craig (12 January 2022). "Davis California based Elevai Labs is raising $2,000,000.00 in New Equity Investment". intelligence360. Retrieved 7 December 2022.
- ↑ "BWL Investments Betting on Medical Aesthetics Growth During Times of Economic Uncertainties". Techtimes. Retrieved 21 June 2023.
- ↑ "ELEVAI Labs, Inc. Announces Pricing of $6,000,000 Initial Public Offering". finance.yahoo.com. Retrieved 19 April 2024.
- ↑ "Braeden Lichti Reported 22.07% Stake In Elevai Labs; Shares Bought For Investment Purpose". moomoo.com. Retrieved 19 April 2024.
- ↑ "HEALTH LOGIC INTERACTIVE ANNOUNCES THE CLOSING OF ITS SALE OF ITS WHOLLY OWNED SUBSIDIARY". www.yahoo.com. Retrieved 7 December 2022.
- ↑ "Lichti Braeden - Activist 13D/13G Filings". fintel.io. Retrieved 13 July 2023.
- ↑ "Braeden William Lichti: Trends in the Aesthetic BioTech Market". Benzinga. Retrieved 7 December 2022.
- ↑ Lichti, Braeden William. "Braeden William Lichti: Trends in the Aesthetic BioTech Market". www.prnewswire.com. Retrieved 7 December 2022.
- ↑ "Author - Braeden Lichti". beautymatter.com. Retrieved 10 December 2022.
- ↑ "MedEsthetics - Ozempic & Aesthetics Take Center Stage On Wall Street". medestheticsmag.texterity.com. Retrieved 19 April 2024.
- ↑ Gallagher, Chris. "The Potential of Shareholder Activism: A Retrospective on Braeden Lichti's Most Recent Campaign". USA TODAY. Retrieved 19 April 2024.
- ↑ "Hydromer, Inc. Announces Resignation of Board Members and Appointment of New Directors". GlobeNewswire News Room (in français). 8 August 2023. Retrieved 15 September 2023.
- ↑ "Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti". GlobeNewswire News Room. 14 September 2023. Retrieved 15 September 2023.